MA26618A1 - Composes et compositions pharmaceutiques pour le traitement du paludisme - Google Patents
Composes et compositions pharmaceutiques pour le traitement du paludismeInfo
- Publication number
- MA26618A1 MA26618A1 MA25522A MA25522A MA26618A1 MA 26618 A1 MA26618 A1 MA 26618A1 MA 25522 A MA25522 A MA 25522A MA 25522 A MA25522 A MA 25522A MA 26618 A1 MA26618 A1 MA 26618A1
- Authority
- MA
- Morocco
- Prior art keywords
- malaria
- compositions
- treatment
- pharmaceutical compounds
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/99—Enzyme inactivation by chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/06—Compounds containing any of the groups, e.g. semicarbazides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/22—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8122198P | 1998-04-09 | 1998-04-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA26618A1 true MA26618A1 (fr) | 2004-12-20 |
Family
ID=22162839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25522A MA26618A1 (fr) | 1998-04-09 | 1999-04-05 | Composes et compositions pharmaceutiques pour le traitement du paludisme |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1068304A4 (fr) |
JP (1) | JP2002511491A (fr) |
KR (1) | KR20010042535A (fr) |
CN (1) | CN1304447A (fr) |
AR (1) | AR020065A1 (fr) |
AU (1) | AU3482099A (fr) |
CA (1) | CA2327282A1 (fr) |
CO (1) | CO5080800A1 (fr) |
DZ (1) | DZ2752A1 (fr) |
HU (1) | HUP0101513A2 (fr) |
IL (1) | IL138628A0 (fr) |
MA (1) | MA26618A1 (fr) |
NO (1) | NO20005032L (fr) |
PE (1) | PE20000421A1 (fr) |
PL (1) | PL343373A1 (fr) |
TR (1) | TR200002940T2 (fr) |
WO (1) | WO1999053039A1 (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6143742A (en) * | 1997-12-11 | 2000-11-07 | Fuisz Technologies Ltd | Treatment for necrotizing infections |
MA26631A1 (fr) * | 1998-05-21 | 2004-12-20 | Smithkline Beecham Corp | Composes a fonction bis-aminomethyl-carbonyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant |
US6083966A (en) | 1998-08-31 | 2000-07-04 | University Of Florida | Thiazoline acid derivatives |
EP1488791A3 (fr) * | 1998-09-21 | 2005-04-06 | University Of Florida Research Foundation, Inc. | Agents contre la malaria |
CN1585639A (zh) | 1998-09-21 | 2005-02-23 | 佛罗里达大学研究基金会 | 抗疟疾制剂 |
CO5150165A1 (es) * | 1998-11-13 | 2002-04-29 | Smithkline Beecham Plc | Inhibidores de proteasa: tipo catepsina k |
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
EP1232154A4 (fr) | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | Inhibiteurs de protease |
AU1474801A (en) | 1999-11-10 | 2001-06-06 | Smithkline Beecham Corporation | Protease inhibitors |
WO2001034599A1 (fr) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Inhibiteurs de protease |
CN1416346A (zh) | 2000-03-21 | 2003-05-07 | 史密丝克莱恩比彻姆公司 | 蛋白酶抑制剂 |
US6635784B2 (en) | 2000-09-29 | 2003-10-21 | Eastman Chemical Company | Process for the preparation of enantiomerically-enriched cyclopropylalanine derivates |
ES2261341T3 (es) * | 2000-11-17 | 2006-11-16 | Medivir Ab | Inhibidor de cisteina proteasa. |
US7132449B2 (en) * | 2001-01-17 | 2006-11-07 | Amura Therapeutics Limited | Inhibitors of cruzipain and other cysteine proteases |
JP2004520365A (ja) | 2001-01-17 | 2004-07-08 | アミュラ テラピューティクス リミテッド | クルジパインおよび他のシステインプロテアーゼの阻害剤 |
ATE356130T1 (de) | 2001-01-17 | 2007-03-15 | Amura Therapeutics Ltd | Inhibitoren von cruzipain und anderen cysteinproteasen |
WO2003062192A1 (fr) | 2002-01-17 | 2003-07-31 | Smithkline Beecham Corporation | Derives de cetoamides a substitution cycloalkyle, utiles comme inhibiteurs de cathepsine k |
US7476653B2 (en) * | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
US8921521B2 (en) | 2003-06-18 | 2014-12-30 | Ocera Therapeutics, Inc. | Macrocyclic modulators of the Ghrelin receptor |
AU2003270473A1 (en) | 2003-09-09 | 2005-04-27 | University Of Florida | Desferrithiocin derivatives and their use as iron chelators |
CN101189216B (zh) | 2005-04-04 | 2011-10-19 | 佛罗里达大学研究基金会 | Desferrithiocin聚醚类似物 |
MX2008001207A (es) * | 2005-07-26 | 2008-03-24 | Merck Frosst Canada Ltd | Inhibidores de la cisteina proteasa de la familia de la papaina para el tratamiento de enfermedades parasitarias. |
JP5439193B2 (ja) | 2007-03-15 | 2014-03-12 | ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. | デスフェリチオシンポリエーテル類似体 |
AU2008329515B2 (en) | 2007-11-29 | 2013-09-05 | Merck Canada Inc. | Cysteine protease inhibitors for the treatment of parasitic diseases |
EP2240491B1 (fr) | 2008-01-09 | 2015-07-15 | Amura Therapeutics Limited | DÉRIVÉS DE TÉTRAHYDROFURO(2,3-b)PYRROL-3-ONE COMME INHIBITEURS DE CYSTÉINE PROTÉINASES |
CN113398126A (zh) | 2011-12-16 | 2021-09-17 | 佛罗里达大学研究基金会 | 4′-去铁硫素类似物的用途 |
EP2633855A1 (fr) | 2012-03-01 | 2013-09-04 | Veterinärmedizinische Universität Wien | Inhibiteurs de la protéase pour le traitement d'infections par Trichomonas gallinae |
AU2014352780A1 (en) | 2013-11-22 | 2016-06-09 | University Of Florida Research Foundation, Inc. | Desferrithiocin analogs and uses thereof |
JP2018515475A (ja) | 2015-04-27 | 2018-06-14 | ユニバーシティー オブ フロリダ リサーチ ファンデーション, インク. | 代謝的にプログラムされた金属キレーターおよびその使用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776718A (en) * | 1995-03-24 | 1998-07-07 | Arris Pharmaceutical Corporation | Reversible protease inhibitors |
EA199800353A1 (ru) * | 1995-10-30 | 1998-12-24 | Смитклайн Бичам Корпорейшн | Ингибиторы протеаз |
DZ2285A1 (fr) * | 1996-08-08 | 2002-12-25 | Smithkline Beecham Corp | Inhibiteurs de protéase de la cystéine. |
MA26487A1 (fr) * | 1997-04-29 | 2004-12-20 | Smithkline Beecham Corp | Heterocyclecetohydrazides inhibiteurs de proteases, procede pour leur preparation et compositions pharmaceutiques les contenant . |
-
1999
- 1999-04-05 MA MA25522A patent/MA26618A1/fr unknown
- 1999-04-07 DZ DZ990053A patent/DZ2752A1/fr active
- 1999-04-07 AR ARP990101578A patent/AR020065A1/es unknown
- 1999-04-08 PL PL99343373A patent/PL343373A1/xx not_active Application Discontinuation
- 1999-04-08 IL IL13862899A patent/IL138628A0/xx unknown
- 1999-04-08 CN CN99807012A patent/CN1304447A/zh active Pending
- 1999-04-08 JP JP2000543587A patent/JP2002511491A/ja not_active Withdrawn
- 1999-04-08 AU AU34820/99A patent/AU3482099A/en not_active Abandoned
- 1999-04-08 CA CA002327282A patent/CA2327282A1/fr not_active Abandoned
- 1999-04-08 TR TR2000/02940T patent/TR200002940T2/xx unknown
- 1999-04-08 EP EP99916517A patent/EP1068304A4/fr not_active Withdrawn
- 1999-04-08 KR KR1020007011178A patent/KR20010042535A/ko not_active Application Discontinuation
- 1999-04-08 HU HU0101513A patent/HUP0101513A2/hu unknown
- 1999-04-08 WO PCT/US1999/007723 patent/WO1999053039A1/fr not_active Application Discontinuation
- 1999-04-08 CO CO99020595A patent/CO5080800A1/es unknown
- 1999-04-09 PE PE1999000290A patent/PE20000421A1/es not_active Application Discontinuation
-
2000
- 2000-10-06 NO NO20005032A patent/NO20005032L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0101513A2 (hu) | 2001-08-28 |
KR20010042535A (ko) | 2001-05-25 |
AU3482099A (en) | 1999-11-01 |
NO20005032D0 (no) | 2000-10-06 |
PE20000421A1 (es) | 2000-05-21 |
PL343373A1 (en) | 2001-08-13 |
CN1304447A (zh) | 2001-07-18 |
EP1068304A1 (fr) | 2001-01-17 |
EP1068304A4 (fr) | 2001-05-09 |
TR200002940T2 (tr) | 2001-02-21 |
CO5080800A1 (es) | 2001-09-25 |
NO20005032L (no) | 2000-11-16 |
IL138628A0 (en) | 2001-10-31 |
CA2327282A1 (fr) | 1999-10-21 |
JP2002511491A (ja) | 2002-04-16 |
DZ2752A1 (fr) | 2003-09-15 |
WO1999053039A1 (fr) | 1999-10-21 |
AR020065A1 (es) | 2002-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA26618A1 (fr) | Composes et compositions pharmaceutiques pour le traitement du paludisme | |
MA26882A1 (fr) | COMPOSITIONS PHARMACEUTIQUES D'INHIBITEURS ET GLYCOGèNE-PHOSPHORYLASE | |
MA26536A1 (fr) | Association de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation. | |
EE05585B1 (et) | Indasoolihendid ja farmatseutilised kompositsioonid proteiini kinaaside inhibeerimiseks ning nende kasutamine | |
FR2808685B1 (fr) | Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires | |
ITMI950529A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
HUP0400529A3 (en) | Use of chlorpromazine and pentamidine for preparation of pharmaceutical compositions for the treatment of neoplastic disorders | |
DZ2596A1 (fr) | Associations pharmaceutiques d'amlodipine et d'atorvastatine et procédé pour leur préparation. | |
FR2722984B1 (fr) | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees | |
FR2775596B1 (fr) | Nouvelles compositions pharmaceutiques | |
NO996352D0 (no) | <Kappa>-antagenist-forbindelser, farmasoeytiske sammensetninger og fremgangsmåte for forebygging og behandling av pruritus | |
MA26553A1 (fr) | Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la | |
MA26621A1 (fr) | Composition pour aerosols pharmaceutiques | |
MA26790A1 (fr) | Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie | |
MA26507A1 (fr) | Compositions pharmaceutiques d'aerosol | |
HUP0201872A3 (en) | Steroid compounds and pharmaceutical compositions of the same | |
FR2786075B1 (fr) | Conditionnement etanche pour compositions cosmetiques et/ou pharmaceutiques | |
DZ2600A1 (fr) | Associations pharmaceutiques d'amlodipine et d'unestatine et procédé pour leur préparation. | |
HUP0201334A2 (en) | Hydrochloride of fused-heterocycle compound and pharmaceutical compositions containing the same | |
DZ2675A1 (fr) | Association pharmaceutique pour le traitement d'undysfunctionnement sexuel et compositions la conte nant. | |
EE200200271A (et) | Ravimkombinatsioonid ning nende kasutamine | |
FR2754177B1 (fr) | Microspheres pharmaceutiques d'acide valproique pour administration orale | |
PT1140110E (pt) | Clatratos de desidroepiandrosterona e correspondentes composicoes farmaceuticas | |
IT1274655B (it) | Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico | |
IL121096A0 (en) | Pharmaceutical compositions for the treatment of liver disease |